FLT3 and acute myeloid leukemia: ,14 Using FLT3-ITD-specific promoter capture HiC data from a reference FLT3-ITD+ AML sample from the same study, we constructed GRNs from purified leukemic blast cells of FLT3-ITD+ AML samples from patients before treatment and after relapse from treatment with FLT3i.